Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?

Platelets. 2021 Nov 17;32(8):1126-1128. doi: 10.1080/09537104.2021.1905159. Epub 2021 Mar 31.
No abstract available

Keywords: Aggregation; aspirin; major adverse cardiovascular and cerebrovascular events; platelet inhibition; rivaroxaban; thromboxane.

Publication types

  • Letter

MeSH terms

  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Chronic Disease / drug therapy*
  • Drug Therapy, Combination / methods*
  • Heart Diseases / drug therapy*
  • Humans
  • Platelet Aggregation / drug effects*
  • Platelet Function Tests / methods*
  • Rivaroxaban / pharmacology
  • Rivaroxaban / therapeutic use*
  • Thromboxanes / adverse effects*

Substances

  • Thromboxanes
  • Rivaroxaban
  • Aspirin